In light of continued uncertainty regarding travel restrictions related to COVID-19, the SPS Board of Directors made the decision to plan for a fully virtual 2021 Annual Meeting over the dates of October 4-8.
As stated in the recently published paper by the IWG (Vargas HM et al, 2020) “The time has come to meaningfully merge nonclinical and clinical data to enable a more comprehensive, but flexible, clinical risk assessment strategy for QTc monitoring”.
As a safety pharmacology leader, your voice matters! the ICH E14/S7B Q&As are still open for comment in some regions, but not for much longer! Stakeholders from ICH Member countries/regions are encouraged to submit their comments to their respective Regulatory Authorities prior to their deadlines.
We invite you to join CSPT on November 25 for their webinar "An Update on COVID-19: Basic and Clinical Perspectives"
We look forward to fulfilling the SPS Mission alongside you in 2021 and beyond.